In Alzheimer's disease (AD), Amyloid beta (A beta) impairs synaptic function by inhibiting long-term potentiation (LTP), and by facilitating long-term depression (LTD). There is now evidence from AD models that A beta provokes this shift toward synaptic depression by triggering the access to and accumulation of PTEN in the postsynaptic terminal of hippocampal neurons. Here we quantified the PTEN in 196,138 individual excitatory dentate gyrus synapses from AD patients at different stages of the disease and from controls with no neuropathological findings. We detected a gradual increase of synaptic PTEN in AD brains as the disease progresses, in conjunction with a significant decrease in synaptic density. The synapses that remain in symptomat...
Alzheimer’s disease (AD) is the most common neurodegenerative disorder, which is clinically associat...
Soluble oligomeric assemblies of amyloid β (Aβo) drive much of Alzheimer’s disease (AD) pathology. A...
Synapse loss is an early and invariant feature of Alzheimer's disease (AD) and there is a strong cor...
In Alzheimer's disease (AD), Amyloid β (Aβ) impairs synaptic function by inhibiting long-term potent...
Memory loss in Alzheimer’s disease (AD) is attributed to pervasive weakening and loss of synapses. H...
Altres ajuts: CIBERNED CB06/05/0042 i BrightFocus Foundation (A2014417S)Alzheimer's disease (AD) is ...
Alzheimer’s disease (AD) ranks sixth on the Centers for Disease Control and Prevention Top 10 Leadin...
The collapse of neural networks important for memory and cognition, including death of neurons and d...
Dyshomeostasis of amyloid-β peptide (Aβ) is responsible for synaptic malfunctions leading to cogniti...
Dynamic gain and loss of synapses is fundamental to healthy brain function. While Alzheimer’s Diseas...
SummaryBeta amyloid (Aβ), a peptide generated from the amyloid precursor protein (APP) by neurons, i...
This is the final version of the article. Available from eLife Sciences Publications via the DOI in ...
Alzheimer’s disease (AD) is an irreversible brain disorder characterized by progressive cognitive de...
Alzheimer's disease (AD) is the most common neurological disease, which is associated with gradual m...
The mechanisms by which amyloid beta (Aβ) causes synaptic dysfunction in Alzheimer’s disease (AD) re...
Alzheimer’s disease (AD) is the most common neurodegenerative disorder, which is clinically associat...
Soluble oligomeric assemblies of amyloid β (Aβo) drive much of Alzheimer’s disease (AD) pathology. A...
Synapse loss is an early and invariant feature of Alzheimer's disease (AD) and there is a strong cor...
In Alzheimer's disease (AD), Amyloid β (Aβ) impairs synaptic function by inhibiting long-term potent...
Memory loss in Alzheimer’s disease (AD) is attributed to pervasive weakening and loss of synapses. H...
Altres ajuts: CIBERNED CB06/05/0042 i BrightFocus Foundation (A2014417S)Alzheimer's disease (AD) is ...
Alzheimer’s disease (AD) ranks sixth on the Centers for Disease Control and Prevention Top 10 Leadin...
The collapse of neural networks important for memory and cognition, including death of neurons and d...
Dyshomeostasis of amyloid-β peptide (Aβ) is responsible for synaptic malfunctions leading to cogniti...
Dynamic gain and loss of synapses is fundamental to healthy brain function. While Alzheimer’s Diseas...
SummaryBeta amyloid (Aβ), a peptide generated from the amyloid precursor protein (APP) by neurons, i...
This is the final version of the article. Available from eLife Sciences Publications via the DOI in ...
Alzheimer’s disease (AD) is an irreversible brain disorder characterized by progressive cognitive de...
Alzheimer's disease (AD) is the most common neurological disease, which is associated with gradual m...
The mechanisms by which amyloid beta (Aβ) causes synaptic dysfunction in Alzheimer’s disease (AD) re...
Alzheimer’s disease (AD) is the most common neurodegenerative disorder, which is clinically associat...
Soluble oligomeric assemblies of amyloid β (Aβo) drive much of Alzheimer’s disease (AD) pathology. A...
Synapse loss is an early and invariant feature of Alzheimer's disease (AD) and there is a strong cor...